2006
DOI: 10.1016/j.cancergencyto.2005.12.006
|View full text |Cite
|
Sign up to set email alerts
|

A complex, four-way variant t(15;17) in acute promyelocytic leukemia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
13
1

Year Published

2008
2008
2017
2017

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 28 publications
(14 citation statements)
references
References 26 publications
0
13
1
Order By: Relevance
“…Our case is the first report of new three-way variant translocation to our knowledge. Yoo [21,25,31]. These findings may indicate that the involvement of 22q11 have no significant role in leukemogenesis and treatment response although we did not verify the implication on any oncogene located in 22q11.…”
Section: Discussioncontrasting
confidence: 75%
“…Our case is the first report of new three-way variant translocation to our knowledge. Yoo [21,25,31]. These findings may indicate that the involvement of 22q11 have no significant role in leukemogenesis and treatment response although we did not verify the implication on any oncogene located in 22q11.…”
Section: Discussioncontrasting
confidence: 75%
“…Several complex variant translocations have been reported in APL with three-way or more complex translocations [5][6][7][8][9][10][11]. To our knowledge, our case is the first report of a new four-way variant translocation of 5q33 and 20q11 involvement in APL.…”
Section: Discussionmentioning
confidence: 59%
“…This fusion transcript is known to play a pivotal role in the pathogenesis of APL and the sensitivity to alltrans retinoic acid (ATRA) [3]. APL patients with alternative translocations, such as t(11;17)(q23;q21) [4] have been reported, and more complex variant (15;17) translocations are increasingly recognized in APL [5][6][7][8][9][10][11]. Molecular and cytogenetic characterization of variant translocations is important for a better understanding of the pathogenesis of the disease and to predict the response to ATRA.…”
Section: Introductionmentioning
confidence: 99%
“…Promyelocytic leukemia (PML), which is encoded by a PML gene mapped on chromosome 15q22 in humans, contains a nuclear localization signal (NLS), an α-helical coiled-coil region and B-Boxes (5). In 1991, it was discovered that the consistent chromosomal translocation of APL, t (15:17), fused the RARα gene to the PML gene on chromosome 15 (6), yielding the fusion protein PML-RARα (7), which represents the etiologic agent of APL. This translocation has become the definitive marker for the disease and is detected in 95% of patients with APL (8).…”
Section: Introductionmentioning
confidence: 99%